How A Doc's FCA Suit Turned Into $1.4B Opioid Deal
An addiction specialist looking to take on Reckitt Benckiser's marketing practices for its opioid treatment found a path to victory by filing a whistleblower suit so that the federal government would...To view the full article, register now.
Already a subscriber? Click here to view full article